Takashima Y, Kawamura H, Okadome K, et al. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype (CIMP)-high colorectal carcinoma. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024. doi:10.1016/j.cmi.2024.01.013.

Worby CJ, Schreiber HL, Straub TJ, et al. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol. 2022;7(5):630-639. doi:10.1038/s41564-022-01107-x.

Lavoie S, Garrett WS. The Unfolding Story of ATF6, Microbial Dysbiosis, and Colorectal Cancer. Gastroenterology. 2018;155(5):1309-1311. doi:10.1053/j.gastro.2018.10.011.

Wlodarska M, Luo C, Kolde R, et al. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. Cell Host Microbe. 2017;22(1):25-37.e6. doi:10.1016/j.chom.2017.06.007.

Song M, Chan AT. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention. Clin Gastroenterol Hepatol. 2019;17(2):275-289. doi:10.1016/j.cgh.2018.07.012.

Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. Nat Rev Genet. 2017;18(11):690-699. doi:10.1038/nrg.2017.63.

Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives T1 cell induction and inflammation. Science. 2017;358(6361):359-365. doi:10.1126/science.aan4526.

Ni J, Shen T-CD, Chen EZ, et al. A role for bacterial urease in gut dysbiosis and Crohn’s disease. Sci Transl Med. 2017;9(416). doi:10.1126/scitranslmed.aah6888.

Schirmer M, Franzosa EA, Lloyd-Price J, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol. 2018;3(3):337-346. doi:10.1038/s41564-017-0089-z.

Mahmoudi M, Pakpour S, Perry G. Drug-Abuse Nanotechnology: Opportunities and Challenges. ACS Chem Neurosci. 2018;9(10):2288-2298. doi:10.1021/acschemneuro.8b00127.